News

Biotaly announces second closing of €45 million Series C financing round

05.03.20

Biotalys raises an additional €10m welcoming specialist US investor Novalis LifeSciences

Biotalys announces collaboration with Chrysal to evaluate potential of biofungicide in flowers

23.01.20

Biotalys nv, a rapidly growing and transformative food and crop protection company developing a new generation of protein-based biocontrols, today announces a collaboration with Chrysal to protect

AgroSavfe announces name change to Biotalys and incorporation of US subsidiary, Biotalys, Inc.

10.12.19

New corporate identity reflects mission to shape the future of sustainable and safe food supply. Incorporation of Biotalys, Inc.

ViroVet receives grant from VLAIO (Flanders) to boost the development of its disruptive vaccine technology

18.09.18

ViroVet nv announced today that it has received a 590.000 euro grant from Flanderes Innovation & Entrepreneurship (VLAIO) to assess the potential of its PLLAV-vaccination technology in poultry